News

The Summer 2017 of the ARMI newsletter, Regenerate, is now available for download in the 'Resources' section. Here are just some of the highlights for ARMI in the final quarter of 2017:

• New discoveries pave the way for improved understanding of stem cell research tools.
• Meet Dr Harald Janovjak. He's a basic biology researcher with a regenerative medicine twist.
• New experience, perspective, and Institute leadership.
• A tale of three countries - The ABC Regenerative Medicine and Developmental Biology Symposia
• ARMI's Master of Biotechnology
• The next generation of regenerative medicine researchers 

Discover what other highlights have emerged and read the diverse range articles in the latest edition of Regenerate.

The Australian Regenerative Medicine Institute (ARMI) is working with Monash University’s Bachelor of Science Advanced - Global Challenges (Honours) course to deliver the next generation of entrepreneurial scientists.

The Australian Regenerative Medicine Institute (ARMI) had the honour of hosting the inaugural ABC Symposium in October. The symposia are part of a longer-term engagement initiative to strengthen institutional relationships between the Brazilian Biosciences National Laboratory (LNBio), University of Campinas (Unicamp, Brazil), University of Chile, Pontifical Catholic University of Chile and ARMI.

We would like to extend a very warm and friendly welcome to Dr Harald Janovjak, ARMI’s newest Group Leader. He is moving to Australia from Vienna, where he was an Associate Professor at the Institute of Science and Technology Austria (IST Austria).

Dr Lusia Guthrie, of ARMI’s Industry Advisory Committee,  awarded the AusBiotech and Johnson & Johnson 2017 Industry Leadership Award. 

In an exciting opportunity, Jeannette Hallab was invited to be a member of the Australian-Lebanese Medical Association (ALMA) health delegation from Australia to Beirut in July 2017.

The Spring 2017 of the ARMI newsletter, Regenerate, is now available for download in the 'Resources' section. Here are just some of the highlights for ARMI in the third quarter of 2017:

ReNerve is a biotechnology startup with tissue engineering technology which has been developed right here in Melbourne. The startup is working with ARMI and its unique laboratory facilities to further develop its technology.

If you looked beyond the outstanding career of Dr Zita Unger as an evaluator, educator and entrepreneur, you would discover that she is a keen diver with extensive experience in the Pacific, Micronesia and Australian waters. For Dr Zita Unger, however, the exploring does not stop in the watery depths. When on dry land, Dr Unger investigates opportunities for ARMI.

Associate Professor Andrew Laslett’s Group at ARMI is focussed on investigating the biology of human pluripotent stem cell lines, including human ESC and iPSC. Thanks to the Laslett Group, the study and application of human embryonic stem cells has recently been advanced by the availability of new antibodies which can easily determine which cells in a cell population are pluripotent.